Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 May 28;7(6):376-378.
doi: 10.1016/j.aace.2021.05.006. eCollection 2021 Nov-Dec.

Paraneoplastic Hypoglycemia Leading to Insulin Independence in a Patient With Type 1 Diabetes

Nami Safai Haeri  1 , Hussain Mahmud  1 , Mary T Korytkowski  1
Affiliations
Case Reports

Paraneoplastic Hypoglycemia Leading to Insulin Independence in a Patient With Type 1 Diabetes

Nami Safai Haeri et al. AACE Clin Case Rep. .

Abstract

Objective: Non-islet cell tumor hypoglycemia (NICTH) is an uncommon paraneoplastic syndrome associated with mesenchymal neoplasms such as gastrointestinal stromal tumors (GISTs). We report the case of a patient with type 1 diabetes (T1D) and recurrent GIST who not only required discontinuation of insulin therapy but also required continuous parenteral glucose infusions to prevent hypoglycemia.

Methods: A 59-year-old woman with a 24-year history of T1D and recurrent GIST presented with frequent episodes of symptomatic hypoglycemia despite continuous reductions in her insulin therapy. Laboratory workup revealed undetectable insulin and C-peptide, low insulin-like growth factor (IGF) 1, normal IGF-2, and an elevated IGF-2:IGF-1 ratio. Medical management with prednisone alone and, later, in combination with octreotide did not reduce hypoglycemic episodes. Eventually, during hospitalization for severe hypoglycemia, she was treated and discharged with continuous intravenous dextrose infusion. She ultimately required around-the-clock glucose infusions, which helped her maintain what she believed was an acceptable quality of life during her remaining weeks.

Discussion: NICTH is characterized by excessive tumor production of IGF-2 or pro-IGF-2, leading to unrestricted glucose uptake in peripheral tissues and hypoglycemia. A diagnosis of NICTH can be made on the basis of low IGF-1 levels in the plasma with normal or elevated IGF-2. Tumor resection is the most definitive treatment for NICTH.

Conclusion: This patient with T1D presented with resistant hypoglycemia due to recurrence of an enlarging GIST. She required discontinuation of all insulin therapy and continuous dextrose infusions to maintain euglycemia.

Keywords: CT, computed tomography; GIST, gastrointestinal stromal tumor; IGF, insulin-like growth factor; IGFBP, insulin-like growth factor binding protein; NICTH, non–islet cell tumor hypoglycemia; T1D, type 1 diabetes; gastrointestinal stromal tumors; hypoglycemia; insulin-like growth factors; paraneoplastic syndrome; type 1 diabetes.

PubMed Disclaimer

References

    1. Marks V., Teale J.D. Tumours producing hypoglycaemia. Diabetes Metab Res Rev. 1991;7(2):79–91. - PubMed
    1. Nadler W.H., Wolfer J.A. Hepatogenic hypoglycemia associated with primary liver cell carcinoma. Arch Intern Med. 1929;44(5):700–710.
    1. Dynkevich Y., Rother K.I., Whitford I. Tumors, IGF-2, and hypoglycemia: insights from the clinic, the laboratory, and the historical archive. Endocr Rev. 2013;34(6):798–826. - PubMed
    1. Corless C.L., Fletcher J.A., Heinrich M.C. Biology of gastrointestinal stromal tumors. J Clin Oncol. 2004;22(18):3813–3825. - PubMed
    1. Heinrich M.C., Corless C.L., Demetri G.D. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol. 2003;21(23):4342–4349. - PubMed

Publication types

LinkOut - more resources